{
    "title": "Eli Lilly pushes back timeline for Alzheimer's drug application",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10472441/Eli-Lilly-profit-beats-higher-Trulicity-sales.html",
    "date": "2022-02-03",
    "keywords": [
        "drug",
        "approval",
        "coverage",
        "donanemab",
        "year",
        "covid19",
        "leo",
        "timeline",
        "application",
        "quarter",
        "medicare",
        "skovronsky",
        "difference",
        "thursday",
        "drugmaker",
        "medicaid",
        "treatment",
        "part",
        "april",
        "class",
        "roche",
        "ag",
        "co",
        "ltd",
        "investor",
        "focus",
        "timing",
        "impact",
        "officer",
        "daniel",
        "company",
        "trial",
        "mid2023",
        "clarity",
        "mizuho",
        "analyst",
        "vamil",
        "diwan",
        "food",
        "administration",
        "decision",
        "olumiant",
        "middle",
        "jump",
        "fourthquarter",
        "revenue",
        "profit",
        "demand",
        "topselling",
        "trulicity",
        "antibody",
        "manojna",
        "maddipatla",
        "bengaluru",
        "editing",
        "dasgupta",
        "shinjini",
        "ganguli"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}